# Immunoexpression Patterns of Megalin, Cubilin, Caveolin-1, Gipc1 and Dab2IP in the Embryonic and Postnatal Development of the Kidneys in Yotari (Dab1−/−) Mice

**Authors:** Sani Žužul, Nela Kelam, Anita Racetin, Petra Kovačević, Suzana Konjevoda, Natalija Filipović, Nikola Pavlović, Katarina Vukojević

PMC · DOI: 10.3390/biomedicines12071542 · Biomedicines · 2024-07-11

## TL;DR

The study compares protein expression patterns in developing mouse kidneys between normal and genetically altered mice to understand kidney development and function.

## Contribution

The study identifies distinct immunoexpression patterns of specific proteins in embryonic and postnatal kidney development in yotari mice.

## Key findings

- Megalin and Cubilin show higher immunoexpression in wild-type mice compared to yotari mice at E13.5.
- Caveolin-1 expression decreases as kidney development progresses.
- Gipc1 and Dab2IP exhibit distinct staining patterns in different kidney regions and developmental stages.

## Abstract

Our study examines the immunoexpression patterns of Megalin, Cubilin, Caveolin-1, Gipc1 and Dab2IP in the embryonic development (E) and postnatal (P) mouse kidney, with a focus on differentiating patterns between wild-type (wt) and yotari, Dab1−/− (yot) mice. Immunofluorescence revealed raised immunoexpression of receptors Megalin and Cubilin at the ampulla/collecting ducts and convoluted tubules across all developmental stages, with the most prominent immunoexpression observed in the convoluted tubules and the parietal epithelium of the Bowman’s capsule. Quantitative analysis showed a higher percentage of Megalin and Cubilin in wt compared to yot mice at E13.5. Co-expression of Megalin and Cubilin was observed at the apical membrane of convoluted tubules and the parietal layer of the Bowman’s capsule. The staining intensity of Megalin varied across developmental stages, with the strongest reactivity observed at the ampulla and collecting ducts at embryonic day (E) 13.5 in wt mice. In contrast, Caveolin-1 exhibited high immunoexpression in the metanephric mesenchyme, blood vessels, and the border area between the metanephric mesenchyme and renal vesicle, with a decrease in immunoexpression as development progressed. Gipc1 showed diffuse cytoplasmic staining in metanephric mesenchyme, convoluted tubules and collecting ducts, with significant differences in immunoexpression between wild-type and yot mice at both investigated embryonic time points. Dab2IP immunofluorescent staining was most prominent in renal vesicle/glomeruli and ampulla/collecting ducts at E13.5, with mild staining intensity observed in the distal convoluted tubules postnatally. Our findings elucidate distinct immunoexpression of patterns and potential parts of these proteins in the development and function of the kidney, highlighting the importance of further investigation into their regulatory mechanisms.

## Linked entities

- **Genes:** Lrp2 (low density lipoprotein receptor-related protein 2) [NCBI Gene 14725], Cubn (Cubilin) [NCBI Gene 326235], CAV1 (caveolin 1) [NCBI Gene 373996], GIPC1 (GIPC PDZ domain containing family member 1) [NCBI Gene 10755], DAB2IP (DAB2 interacting protein) [NCBI Gene 153090], DAB1 (DAB adaptor protein 1) [NCBI Gene 1600]
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Dab2ip (disabled 2 interacting protein) [NCBI Gene 69601] {aka 2310011D08Rik, Aip1, mKIAA1743}, Gipc1 (GIPC PDZ domain containing family, member 1) [NCBI Gene 67903] {aka GIPC, Glut1CIP, Rgs19ip1, Semcap1, TIP-2, TaxIP2}, Lrp2 (low density lipoprotein receptor-related protein 2) [NCBI Gene 14725] {aka D230004K18Rik, Gp330, Megalin, b2b1625.2Clo}, Dab1 (disabled 1) [NCBI Gene 13131] {aka C630028C02Rik, mDab1, scm, scr, scrambler, yot}, Cav1 (caveolin 1, caveolae protein) [NCBI Gene 12389] {aka Cav, Cav-1}, Cubn (cubilin) [NCBI Gene 65969] {aka D2Wsu88e}
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11274389/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11274389/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC11274389/full.md

---
Source: https://tomesphere.com/paper/PMC11274389